Morgan Stanley's Base Case on Shopify (SHOP) Suggests 71% Upside, Bull Case 207%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Wedbush Starts Shopify (SHOP) at Outperform
January 21, 2016 7:28 AM ESTWedbush initiates coverage on Shopify (NYSE: SHOP) with a Outperform rating and a price target of $25.00.
Analyst Gil Luria commented, "We believe ecommerce enablers are best positioned to take advantage of the secular shift of retail online and that Shopify represents a best-in-class... More
Pre-Open Stock Movers 01/19: (RSE) (ZPIN) (SHOP) Higher; (EBIO) (TIF) (MKC) Lower (more...)
January 19, 2016 9:33 AM ESTEleven Biotherapeutics, Inc. (NASDAQ: EBIO) 64% LOWER; announced top-line results from the Phase 3 clinical trial of its lead drug candidate, isunakinra (EBI-005), for the treatment of severe allergic conjunctivitis. In this trial, there were no statistically significant differences between the isunakinra treated group and the vehicle control group on the primary endpoint of ocular itching or on any secondary endpoints. Isunakinra was generally well tolerated, with 94% of the patients completing the trial and there were no serious adverse events reported.
Rouse Properties, Inc. (NYSE:... More
Morgan Stanley Upgrades Shopify (SHOP) to Overweight
January 19, 2016 6:47 AM ESTMorgan Stanley upgraded Shopify (NYSE: SHOP) from Equalweight to Overweight.
For an analyst ratings summary and ratings history on Shopify click here. For more ratings news on Shopify click here.
Shares of Shopify closed at $19.89 yesterday.
... More